Westside Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29K | Sell |
149
-3
| -2% | -$622 | ﹤0.01% | 790 |
|
|
2026
Q1 | $34.1K | Hold |
152
| – | – | 0.01% | 693 |
|
|
2025
Q4 | $37.1K | Buy |
152
+20
| +15% | +$5.12K | 0.01% | 642 |
|
|
2025
Q3 | $35.8K | Buy |
132
+66
| +100% | +$18K | 0.01% | 660 |
|
|
2025
Q2 | $16.9K | Sell |
66
-153
| -70% | -$36.5K | ﹤0.01% | 739 |
|
|
2025
Q1 | $49.2K | Hold |
219
| – | – | 0.01% | 408 |
|
|
2024
Q4 | $50.3K | Hold |
219
| – | – | 0.01% | 406 |
|
|
2024
Q3 | $53.7K | Hold |
219
| – | – | 0.01% | 395 |
|
|
2024
Q2 | $42.1K | Hold |
219
| – | – | 0.01% | 411 |
|
|
2024
Q1 | $43.5K | Hold |
219
| – | – | 0.01% | 397 |
|
|
2023
Q4 | $37.8K | Hold |
219
| – | – | 0.01% | 398 |
|
|
2023
Q3 | $32.5K | Hold |
219
| – | – | 0.01% | 408 |
|
|
2023
Q2 | $48K | Hold |
219
| – | – | 0.01% | 358 |
|
|
2023
Q1 | $48.1K | Hold |
219
| – | – | 0.01% | 360 |
|
|
2022
Q4 | $45 | Hold |
219
| – | – | ﹤0.01% | 423 |
|
|
2022
Q3 | $47 | Hold |
219
| – | – | ﹤0.01% | 415 |
|
|
2022
Q2 | $46 | Hold |
219
| – | – | ﹤0.01% | 413 |
|
|
2022
Q1 | $53 | Hold |
219
| – | – | ﹤0.01% | 409 |
|
|
2021
Q4 | $57 | Hold |
219
| – | – | ﹤0.01% | 390 |
|
|
2021
Q3 | $57 | Hold |
219
| – | – | ﹤0.01% | 382 |
|
|
2021
Q2 | $54 | Hold |
219
| – | – | ﹤0.01% | 377 |
|
|
2021
Q1 | $42 | Buy |
219
+1
| +0.5% | +$201 | ﹤0.01% | 390 |
|
|
2020
Q4 | $46 | Hold |
218
| – | – | ﹤0.01% | 350 |
|
|
2020
Q3 | $37 | Buy |
218
+1
| +0.5% | +$185 | ﹤0.01% | 370 |
|
|
2020
Q2 | $41 | Hold |
217
| – | – | ﹤0.01% | 344 |
|
|
2020
Q1 | $32 | Buy |
+217
| New | +$34.6K | ﹤0.01% | 367 |
|
|
2019
Q2 | $26 | Buy |
+215
| New | +$23.8K | ﹤0.01% | 374 |
|
|
2018
Q4 | $24.4K | Buy |
214
+2
| +0.9% | +$214 | 0.01% | 364 |
|
|
2018
Q3 | $24.6K | Sell |
212
-1
| -0.5% | -$110 | 0.01% | 326 |
|
|
2018
Q2 | $22.1K | Buy |
213
+2
| +0.9% | +$202 | 0.01% | 393 |
|
|
2018
Q1 | $20.3K | Hold |
211
| – | – | 0.01% | 387 |
|
|
2017
Q4 | $18.6K | Buy |
211
+1
| +0.5% | +$83 | 0.01% | 421 |
|
|
2017
Q3 | $16K | Buy |
210
+1
| +0.5% | +$76 | 0.01% | 443 |
|
|
2017
Q2 | $16.1K | Hold |
209
| – | – | 0.01% | 421 |
|
|
2017
Q1 | $14.4K | Buy |
209
+2
| +1% | +$138 | 0.01% | 415 |
|
|
2016
Q4 | $13.3K | Buy |
+207
| New | +$12.7K | 0.01% | 343 |
|
Other funds holding RMD
Westside Investment Management's RMD Position: Q2 2026 in Review
Westside Investment Management reduced its ResMed (RMD) stake by 2% in Q2 2026, selling an estimated $622 and leaving 149 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #790.
Westside Investment Management first reported a position in RMD in Q4 2016 and has held it in 36 quarters since. The position peaked at $53.7K in Q3 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Westside Investment Management held 149 shares of ResMed worth $29K as of Q2 2026.
- Westside Investment Management sold 3 ResMed shares in Q2 2026, an estimated $622.
- ResMed made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #790 holding.
- Westside Investment Management first reported a position in ResMed in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's ResMed position peaked at $53.7K in Q3 2024.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.